It's staggering the potential here isnt it?
As I've said before topical prescriptions in US for Rosacea total 3.6m annually. Just think on that opportunity too. I'd like to see a good phase 2 trial and a licence out/JV for phase 3.
BOT - Anything but charting, page-6998
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.015(3.61%) |
Mkt cap ! $725.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.175M | 7.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 407176 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 73139 | 4 |
View Market Depth
| Last trade - 14.34pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |